Originally published April 17 2015
Ebola-infected health worker being treated at NIH hospital now in "critical" condition
by Ethan A. Huff, staff writer
(NaturalNews) The health status of the 11th U.S. patient to be treated for Ebola has worsened from serious to critical condition, according to new reports. The unnamed patient, a health worker who was admitted to the National Institutes of Health (NIH) in Bethesda, Maryland, on March 13, had initially been admitted to the hospital in serious condition, only to quickly degenerate to critical status.
The identity of the patient, and whether or not it's a male or female, has not been publicly disclosed. But reports indicate that the patient is being held in a special isolation unit similar to the one in which nurse Nina Pham of Dallas, Texas, was treated. Officials at NIH say that no other suspected or confirmed Ebola patients are currently being treated at the hospital.
The patient had reportedly traveled to Ebola-stricken areas of Africa prior to catching Ebola and was later brought back to the U.S. by charter plane for treatment at the NIH. The only information about the patient being made publicly available is the fact that he or she had been volunteering in an Ebola treatment unit in Sierra Leone before contracting the virus.
"We knew that Sierra Leone was still simmering and people were still getting infected in Sierra Leone," stated Bobby Gborgar Joe, an educational specialist at Maryland's Department of Human Resources, to CBS Baltimore about the developments. Joe has already lost 16 family members in Liberia to Ebola. "[B]ecause of the close proximity," he added, "we knew that sooner or later somebody was going to show up."
This latest U.S. Ebola patient represents the second one to be treated at the NIH for the disease since the current outbreak was identified more than a year ago. Since that time, 10 others besides the new patient have been treated for Ebola at various U.S. hospitals.
Ebola false flag sparks mass vaccination push for measles? Reluctant to let a good crisis go to waste, several major industries are eagerly trying to capitalize on the Ebola outbreak, including the vaccine industry. The World Health Organization (WHO) recently made an announcement urging mass vaccinations for measles, pertussis and other so-called "vaccine-preventable" diseases throughout West Africa in response to the continued fallout.
"We are calling for the intensification of routine immunization services in all areas, and for mass measles vaccination campaigns in areas that are free of Ebola transmission," stated Dr. Jean-Marie Okwo-Bele, Director of Immunization, Vaccines and Biologicals at WHO.
The organization noted: "Any disruption of immunization services, even for short periods, will result in an increase in the number of susceptible individuals, and will increase the likelihood of vaccine-preventable disease outbreaks."
What a convenient and utterly unscientific bit of propaganda from WHO on behalf of the vaccine industry, which is chomping at the bit to expand its market in impoverished Africa. Somehow, injecting African babies with aluminum adjuvants, live viruses, aborted human fetal tissue and chemical preservatives will magically make Ebola go away, according to WHO.
Not to be outdone in exploiting Africa for financial gain, internet search giant Google also announced that it has designed a special "Ebola-proof tablet" capable of withstanding chlorine dousing, high humidity, storms and other elements that would destroy an Apple iPad in a matter of seconds.
"The Android device, based in a waterproof Sony Xperia with an extra protective casing, allows medics to safely record and share patient temperatures and symptoms over days and weeks," wrote Aislinn Laing for The Telegraph. "Its manufacturers say it can withstand the storms and high humidity that are commonplace in the Ebola zone of West Africa."
Sources for this article include:
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml